the story of glp 1 Timeline GLP-1 discovery and clinical development. (a) Key events in and more with this must The GLP-1 Conversation Christians Aren't

BrownAJGoldsworthySMBarnesAAEilertMMTcheangLDanielsDet al

But fertility is a team effort

Abbreviations ADA: American Diabetes Association CV: Cardiovascular CVOTs: Cardiovascular outcome trials GLP-1RA: Glucagon-like peptide-1 receptor agonists HR: Hazard ratios MACE: Major cardiovascular events SGLT-2i: Sodiumglucose transporter-2 inhibitors T2DM: Type 2 diabetes mellitus References Giugliano D, Maiorino MI, Longo M, Bellastella G, Chiodini P, Esposito K

Implications for employers: GLP-1 medications can cause GI problems and that is why starting doses are gradually increased

Important Cautions: Side Effects and Stopping the Drugs GLP-1 medications are effective but carry significant side effects, particularly during dose escalation

[DOI] [PubMed] [Google Scholar] 328.Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W